Companies selling probiotic foods had for a long time widely
popularised the benefits of cultivating healthy gut bacteria but
neuroscientists had reservations about the same. Gut bacteria together in
scientific parlance are referred to as microbiome. Probiotics are ingested
microorganisms associated with beneficial effects to humans. These are basically
good bacteria. The concept has been introduced way back in 1907 by the Nobel
Laureate Eli Metchinkoff who suggested that “the dependence of the intestinal
microbes on the food makes it possible to adopt measures to modify the flora in
our bodies and to replace the harmful microbes with useful microbes”. It is
known that digestive tract is home for trillions of bacteria and they account
for 3% of the body weight. Studies show that these bacteria affect the dense
network of neurons in the gut, now deemed as the second brain. A microbial
imbalance in the gut or dysbiosis has been associated with chronic fatigue,
obesity, physical ailments and certain types of cancer. Though the exact
mechanism through which these bacteria can cause or cure the ailments is known
but growing evidence has sparked greater interest among the scientists towards
probiotic research.
Scientists of California Institute of Technology, Pasadena
believes that bacterial waste products have an influence on the brain. Particularly
the Vagus nerve that connects digestive tract to the brain might have an
important role to play. Two types of intestinal bacteria are found to produce ϒ-
amino butyric acid (GABA), a neurotransmitter. The new observations assume
greater significance due to the dogma of nothing can cross the brain-blood
barrier prevalent in the scientific community. This essentially means that brain
is sealed off from rest of the body and protected from infection. But new
evidence effectively shows that there is an apparent communication between the
brain and the gut.
In an experiment carried out at University of Cork, Ireland
found that mice born by caesarean section had a different microbial composition
compared to the vaginally delivered mice. The former were more anxious and had
symptoms of anxiety. Inability to pick up mother’s vaginal bacteria may have
led to lifelong changes in mental health.
Mice with autism were found to have low levels of common gut
bacterium Bacteriodes fragilis than
the normal mice. These animals were stressed, antisocial and had gastrointestinal
symptoms characteristic of autism. Symptoms were reversed when then mice were
fed with B.fragilis. The stressed
mice were also found to contain higher levels of bacterial metabolite 4-ethyl
phenyl sulphate (EPS) in their blood. When normal mice were injected with EPS
it exhibited similar behavioural symptoms as autistic mice. Though the
mechanism of action is unclear, the changes in the behaviour may be outcome of a
leaky gut since the chemical seeped into body through intestinal wall. These
observations raise the possibility of Probiotics as a promising therapy for
autism as they target gut instead of brain which is a more complex and
inaccessible organ.
Currently there is a great excitement about the role played
by the microbiome on the body hence large scale DNA profiling had been
initiated to identify various bacterial species of the gut. Probiotics are
becoming increasingly popular international organisations like FAO (Food and
Agriculture Organisation) and WHO (World Health Organisation) has also
validated certain of the recommendations of the probiotic research. Both the
organisations have endorsed the use of probiotics as an effective ‘alternative’
besides the recommended medications for regression of psychological disorders and other body ailments.
@ Copyrights reserved.
No comments:
Post a Comment